| 18.09.2023 | CDDF workshop on “innovative oncology clinical trial designs”, Amsterdam | Estimands - industry perspective | slides | |
| 30.08.2023 | ISCB44 2023 Milan | Stop the abuse: A plea for a more principled approach to the analysis of time-to-event endpoints with competing risks, with a focus on analysis of AEs | slides | video | Short version of this talk, which starts at 58:20 of the recording. |
| 09.08.2023 | JSM 2023 Toronto | Assurance in drug development | slides | |
| 12.04.2023 | BBS seminar: Quantification of risk: ask the right questions or time to apply the estimand framework to safety! | Stop the abuse: A plea for a more principled approach to the analysis of time-to-event endpoints with varying follow-up times and/or competing risks, with a focus on analysis of AEs. | slides | video | Long version of this talk, given at BBS seminar. |
| 08.08.2022 | JSM 2022 Washington DC (virtual talk) |
MIRROS: Planning a Phase 3 Trial with Time-to-event Endpoint, a Cure Proportion, and a Futility Interim Analysis using Response | slides | |
| 22.02.2022 | University of Ulm | Efficient effect estimation in pre-specified subgroups in forest plots for a time-to-event endpoint | slides | |
| 10.09.2018 | 14th Basel Modeling & Simulation Seminar | Immortal bias - you live longer if you cannot die! | slides | |
| 28.04.2016 | BBS spring seminar | Event projection: quantify uncertainty and manage expectations of broader teams | slides |
Comprehensive list of talks
A pdf file listing all my talks can be downloaded.
Talks for download
Invited talks
Contributed talks
| 28.08.2023 | ISCB44 2023 Milan / CEN 2023 Basel |
Clinical trial design based on a multistate model that jointly models progression-free and overall survival | slides | video | Recording from Milan. |
| 22.08.2022 | ISCB43 2022 Newcastle | Follow-up time in clinical trials with a time-to-event endpoint: Rede ning the question(s) | slides |